Chief Psychiatrist and Medical Director Children's Health Council
Psychiatry
Dr. Glen R. Elliott, MD
|
|
Give Review
Glen R. Elliott works in the field of Psychiatry. He went to medical school at Stanford University School of Medicine. Stanford University School of Medicine is one of the top medical schools in the US. Stanford University School of Medicine is ranked 2 in research and 25 in primary care medicine He has 1 awards "Regional Top Doctor". Glen Elliott is also published. He has 40 publications published. The lastest publication: "S-adenosylmethionine-dependent N-methyltransferase activity in autopsied brain parts of chronic schizophrenics and controls.'
Publications
- Blood Pressure and Heart Rate Over 10 Years in the Multimodal Treatment Study of Children With ADHD.
- Pharmacological cognitive enhancers: Comment on Smith and Farah (2011).
- Psychopharmacology of Depression in children and adolescents.
- Tetrahydrobiopterin as a novel therapeutic intervention for Autism.
- Delinquent Behavior and emerging substance use in the MTA at 36 months: prevalence, course, and treatment effects.
- Effects of stimulant medication on growth rates across 3 years in the MTA follow-up.
- Secondary evaluations of MTA 36-month outcomes: propensity score and growth mixture model analyses.
- 3-year follow-up of the NIMH MTA study.
- Treatment-related changes in objectively measured parenting behaviors in the multimodal treatment study of children with attention-deficit/hyperactivity Disorder.
- Improving recruitment and funding in psychiatry by teaching college undergraduates.
- Altered neural substrates of cognitive control in childhood ADHD: evidence from functional magnetic resonance imaging.
- Peer-assessed outcomes in the multimodal treatment study of children with attention deficit hyperactivity Disorder.
- Nine months of multicomponent behavioral treatment for ADHD and effectiveness of MTA fading procedures.
- Depression in the child and adolescent.
- Effects of ethnicity on treatment attendance, stimulant response/dose, and 14-month outcome in ADHD.
- Response to methylphenidate in children with attention deficit hyperactivity Disorder and manic symptoms in the multimodal treatment study of children with attention d...
- Emergency/Adjunct services and attrition prevention for randomized clinical trials in children: the MTA manual-based solution.
- Socioeconomic status as a moderator of ADHD treatment outcomes.
- The MTA at 8 years: prospective follow-up of children treated for combined-type ADHD in a multisite study.
- Response to commentary on the multimodal treatment study of ADHD (MTA): mining the meaning of the MTA.
- Methylphenidate dosage for children with ADHD over time under controlled conditions: lessons from the MTA.
- Comments on ''Cytogenetic effects in children treated with methylphenidate'' by El-Zein et al.
- Medication adherence in the MTA: saliva methylphenidate samples versus parent report and mediating effect of concomitant Behavioral treatment.
- Impairment and deportment responses to different methylphenidate doses in children with ADHD: the MTA titration trial.
- Multimodal treatment of ADHD in the MTA: an alternative outcome analysis.
- Clinical relevance of the primary findings of the MTA: success rates based on severity of ADHD and ODD symptoms at the end of treatment.
- ADHD comorbidity findings from the MTA study: comparing comorbid subgroups.
- Symptom profiles in children with ADHD: effects of comorbidity and gender.
- The use of signal detection theory to assess DSM-III-R criteria for autistic Disorder.
- An adolescent who abruptly stops his medication for attention-deficit hyperactivity Disorder.
- The ultimate stigma: inadequate funding for research on mental illness and addictive Disorders.
- Cardiovascular effects of desipramine in children.
- Dilemmas for clinicians and researchers using antidepressants to treat adolescents with Depression.
- Effects of intravenous secretin on language and behavior of children with Autism and gastrointestinal symptoms: a single-blinded, open-label pilot study.
- Tricyclic antidepressants: a risk for 6-9 year olds?
- Sudden death and tricyclic antidepressants: clinical considerations for children.
- Postmortem pharmacokinetics of tricyclic antidepressants: are some deaths during treatment misattributed to overdose?
- S-adenosylmethionine-dependent N-methyltransferase activity in autopsied brain parts of chronic schizophrenics and controls.
- The interface between borderline personality Disorder and affective Disorder.
Schools
Stanford University School Of Medicine
Stanford
McLean Hospital Harvard Med School
Michigan State Univerisity
Procedures Preformed
- ADHD Testing
Conditions Treated
- Adjustment Disorder
- Anxiety
- Attention Deficit Disorder (ADD)
- Attention Deficit Hyperactivity Disorder (ADHD)
- View All
Doctors Specialties
- Psychiatry
Accepted Insurances
Awards
- Regional Top Doctor
Education
-
Stanford University -
Massachusetts General Hospital -
Stanford University School of Medicine
Hospital
-
Stanford Health Care
Helpful Reviews
Similar Doctors
|
Dr. Daryn S. Reicherter, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Anthony J. Mascola, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Javaid I. Sheikh, MD
This Doctor is OpenDoctor Recommended.
 This doctor has more publications
|
|
|
Dr. Amit Etkin, MD |
|
|
Dr. Jared R. Tinklenberg, MD
This Doctor is OpenDoctor Recommended.
This doctor has more publications
|
|
|
Dr. Pegah Pajouhi, MD |
|
|
Dr. Mala S. Nayak, MD
This Doctor is OpenDoctor Recommended.
|